These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17120814)

  • 1. Development and validation of a reversed-phase HPLC method for monitoring of synthetic reactions during the manufacture of a key intermediate of an anti-hypertensive drug.
    Rao RN; Nagaraju D; Jena N; Kumaraswamy G
    J Sep Sci; 2006 Oct; 29(15):2303-9. PubMed ID: 17120814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation, characterization, and quantitation of process-related substances of the anti-hypertensive drug doxazosin mesylate by reversed-phase LC with PDA and ESI-MS as detectors.
    Nageswara Rao R; Nagaraju D; Das AK; Jena N
    J Chromatogr Sci; 2007 Feb; 45(2):63-9. PubMed ID: 17425134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation and estimation of process-related impurities of gefitinib by reverse-phase high-performance liquid chromatography.
    Chandrashekara KA; Udupi A; Reddy CG
    J Chromatogr Sci; 2014 Sep; 52(8):799-805. PubMed ID: 23897663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a liquid chromatographic method for monitoring of process-related synthetic organic impurities of profenofos in technical products.
    Nageswara Rao R; Naga Raju D; Venkateswarlu N; Vittal Rao B; Parvathi N; Manjula A; Reddy GN; Gawali PB; Sreekanth M; Nageswara Rao P
    J Chromatogr Sci; 2003 Sep; 41(8):418-21. PubMed ID: 14558934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a validated RP-LC/ESI-MS-MS method for separation, identification and determination of related substances of tamsulosin in bulk drugs and formulations.
    Nageswara Rao R; Kumar Talluri MV; Narasa Raju A; Shinde DD; Ramanjaneyulu GS
    J Pharm Biomed Anal; 2008 Jan; 46(1):94-103. PubMed ID: 17951020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous separation and determination of coenzyme Q(10) and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS).
    Nageswara Rao R; Kumar Talluri MV; Shinde DD
    J Pharm Biomed Anal; 2008 Jun; 47(2):230-7. PubMed ID: 18243624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of alfuzosin hydrochloride in pharmaceutical formulations by RP-HPLC.
    Ganesh M; Uppatyay S; Tivari R; Kamalakannan K; Rathinavel G; Gangully S; Sivakumar T
    Pak J Pharm Sci; 2009 Jul; 22(3):263-6. PubMed ID: 19553171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a reversed phase liquid chromatographic method for separation and determination of related-substances of modafinil in bulk drugs.
    Nageswara Rao R; Shinde DD; Kumar Talluri MV
    Talanta; 2007 Sep; 73(3):407-14. PubMed ID: 19073048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a liquid chromatographic method for determination of related-substances of mosapride citrate in bulk drugs and pharmaceuticals.
    Nageswara Rao R; Nagaraju D; Alvi SN; Bhirud SB
    J Pharm Biomed Anal; 2004 Nov; 36(4):759-67. PubMed ID: 15533668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and substantiation of a liquid chromatographic method for monitoring organic reactions involved in synthesis of 4-methoxyphenylacetic acid.
    Rao RN; Nagaraju D; Parimala P; Adapa SR; Alam MM
    J Chromatogr A; 2002 Oct; 972(2):277-82. PubMed ID: 12416886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion-pairing high-performance liquid chromatographic method for the determination of 5-aminosalicylic acid and related impurities in bulk chemical.
    Kersten BS; Catalano T; Rozenman Y
    J Chromatogr; 1991 Dec; 588(1-2):187-93. PubMed ID: 1818083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an HPLC method for the determination of process-related impurities in pridinol mesylate, employing experimental designs.
    Bianchini RM; Castellano PM; Kaufman TS
    Anal Chim Acta; 2009 Nov; 654(2):141-7. PubMed ID: 19854345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of process related impurities of olanzapine using HPLC and ESI-MS/MS.
    Rao RN; Raju AN; Narsimha R; Babu GR
    J Sep Sci; 2008 Jan; 31(1):107-18. PubMed ID: 18080239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of reversed phase high performance liquid chromatographic method for determination of moxonidine in the presence of its impurities.
    Milovanović S; Otašević B; Zečević M; Zivanović L; Protić A
    J Pharm Biomed Anal; 2012 Feb; 59():151-6. PubMed ID: 22071445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a reversed phase liquid chromatographic method for analysis of oxytetracycline and related impurities.
    Kahsay G; Shraim F; Villatte P; Rotger J; Cassus-Coussère C; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Mar; 75():199-206. PubMed ID: 23277151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of degradation products of citalopram and process-related impurities using RP-HPLC.
    Rao RN; Raju AN; Narsimha R
    J Sep Sci; 2008 Jun; 31(10):1729-38. PubMed ID: 18481321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
    El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
    Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a liquid chromatographic method for the simultaneous determination of aniracetam and its related substances in the bulk drug and a tablet formulation.
    Papandreou G; Zorpas K; Archontaki H
    J Pharm Biomed Anal; 2011 Nov; 56(3):615-22. PubMed ID: 21742456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel HPLC method for analysis of atosiban and its five related substances in atosiban acetate injection.
    Li Q; Huang Y; Zhang Y; Cui H; Yin L; Li Y; Yuan A; Hu Y; Wu J
    J Pharm Biomed Anal; 2020 Jan; 177():112808. PubMed ID: 31585328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validated specific HPLC methods for determination of prazosin, terazosin and doxazosin in the presence of degradation products formed under ICH-recommended stress conditions.
    Bakshi M; Ojha T; Singh S
    J Pharm Biomed Anal; 2004 Jan; 34(1):19-26. PubMed ID: 14738915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.